跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
帕利哌酮缓释片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Paliperidone Extended-Release Tablets
Approved
化学药品
Paliperidone Extended-Release Tablets
SUN PHARMACEUTICAL INDUSTRIES LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Mar 1, 2022
Approval ID
8EflbPbaEXq
Company
SUN PHARMACEUTICAL INDUSTRIES LIMITED
Type
化学药品
Approval Details
Approval Id
8EflbPbaEXq
Approval Number
国药准字HJ20220013
Generic Name
帕利哌酮缓释片
Generic Name En
Paliperidone Extended-Release Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
3mg
Reg Date
2022-03-01
Expired Date
2027-02-28
Company Name
SUN PHARMACEUTICAL INDUSTRIES LIMITED
Production Company Name
SUN PHARMACEUTICAL INDUSTRIES LIMITED
Company Detail Path
/organization/sun-pharmaceutical-industries-limited
Production Company Detail Path
/organization/sun-pharmaceutical-industries-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 1, 2022
Approval ID
8EflbPbaEXq
Type
化学药品
Back to NMPA Approvals